Invention Grant
![Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide](/docs/US/2017-12-26/US09850199B2/abs.jpg.600x600.jpg)
- Patent Title: Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
-
Application No.: US15447946Application Date: 2017-03-02
-
Publication No.: US09850199B2Publication Date: 2017-12-26
- Inventor: Marlene Michelle Dressman , Deepak Phadke
- Applicant: Vanda Pharmaceuticals, Inc.
- Applicant Address: US DC Washington
- Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- Main IPC: C07C231/12
- IPC: C07C231/12
![Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide](/abs-image/US/2017/12/26/US09850199B2/abs.jpg.150x150.jpg)
Abstract:
Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.
Public/Granted literature
- US20170174617A1 METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE Public/Granted day:2017-06-22
Information query
